In April 2026, Gyre initiated its adaptive Phase 2/3 clinical trial in oncology-related pulmonary complications, with the first patient enrolled. The trial is evaluating pirfenidone for ...

Full year 2026 revenue guidance of $100.5 to $111.0 million affirmed NDA for F351 (hydronidone) for CHB-associated liver fibrosis submitted to ...

Shoulder Innovations, Inc. (SI) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to a loss of $52.13 per share a year ago. These ...

Nearly 269,000 tons of plastic pollution may be floating in the world's oceans, according to a new study. Microplastic pollution is found in varying concentrations throughout the oceans, but estimates ...

The findings, published Monday in Nature Climate Change, show that colored micro- and nanoplastics suspended in the ...

A new study published in Nature Climate Change found that colored microplastics suspended in the atmosphere may contribute ...

The Loop Current often bulges out in the northern Gulf of Mexico, where it sometimes sheds a clockwise-rotating ring of warm water that separates from the main current. This ring of warm water – ...

New study: microbes 'take turns' with nutrients from surface to 2.5 miles deep, preserving ocean biodiversity.

University of Hawai‘i at Mānoa oceanographers discovered that microbial communities in the North Pacific Subtropical Gyre — ...

For decades, the conversation around microplastics focused on what they were doing to our oceans, our soil, and our bodies.

Far out in the North Atlantic, roughly 590 miles east of Florida, a sprawling patch of water drifts in slow rotation. It ...

Detailed price information for Cadrenal Therapeutics Inc (CVKD-Q) from The Globe and Mail including charting and trades.